provider_review · verified 2026-08-08

Found review

The strongest clinical bench in this module, and a $49 that needs two conditions

Five named physicians including a former medical director of the obesity-medicine board — and a headline $49 that requires both a twelve-month commitment and commercial insurance, on a plan billed every four weeks.

How this site makes money

Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.

visit Found

at_a_glance

price: "$49/mo" is the figure attached to the non-GLP-1 Generics Plan. It appears nowhere on `/plans-and-pricing`; the real table is an image inside the binding Offer Terms.
what you pay: $89 a month with commercial insurance, or $149 cash-pay, for the Generics Plan bought a month at a time — billed every four weeks. $49 is the twelve-month insured rung and $99 the twelve-month cash rung. On the compounded GLP-1 plan the Offer Terms give $199 insured and $299 cash month to month, falling to $149 and $199 at twelve months.
pharmacy: Not named — but the category is claimed specifically, and about its own supply rather than in the abstract: its compounded-semaglutide page states that Found "partners exclusively with 503A-licensed pharmacies", and the medication is described as third-party tested for potency, purity and sterility. That is the category without the facility, which is half an answer; it is also the better half, because several companies covered on this site mention 503A only inside a general sentence about how pharmacies are regulated, which is not a claim about who fills their prescriptions at all. The clinical bench, by contrast, is the most substantial in this module: Dr Rekha Kumar MD MS (senior medical advisor, former ABOM medical director), Dr Jonathan Larson MD MBA (medical director), Dr Judith Korner MD PhD of Columbia, Dr Shebani Sethi MD of Stanford and Dr Kyu Rhee MD MPP — with Found disclosing on its own pages that Dr Kumar does not interact directly with Found patients.
states: Forty-one states are listed as having insurance plans accepted, and the same page contradicts itself twice: New Mexico renders an "available plans" panel while being absent from the 41-state selector, and California appears in the accepted list while its own panel reads "No plans available for this state."
on our index: Not ranked. Not ranked on /best-nad and not eligible to be: Found's entire formulary is fourteen weight-loss medications — GLP-1 injectables, two oral GLP-1s, and Contrave, metformin, topiramate and zonisamide. There is no NAD+, no peptide, no B-12, nothing for energy, cognition or longevity. It is surfaced only inside the clearly labeled GLP-1 adjacent module on our NAD+-for-weight-loss page, where the argument being made is that NAD+ does not cause weight loss and GLP-1 medications do. It is reviewed here because we link to it and are paid when a reader starts care through that link.

verdict

The short version

Found is the most clinically credible company in the GLP-1 module on this site, and its pricing page is the least reliable thing about it. The bench is real and named: Dr Rekha Kumar MD MS, a former medical director of the American Board of Obesity Medicine, sits as senior medical advisor alongside a medical director and physicians from Columbia and Stanford — and Found itself discloses that Dr Kumar does not interact directly with patients, which is the kind of qualifier most companies leave for someone else to find. Against that, the numbers disagree with each other. The "$49" attached to the non-GLP-1 generics plan requires both a twelve-month commitment and commercial insurance; month to month it is $89 with insurance and $149 cash-pay. And the binding Offer Terms contradict the marketing page on three of four cells for the compounded GLP-1 plan. If NAD+ is what brought you here, the shortest useful sentence is that Found does not sell it or anything like it.

evidence

What the evidence for this route shows

The route question this site normally asks does not apply here, and forcing it would be worse than saying so plainly: Found sells no NAD+ in any form, so there is no NAD+ delivery route to assess. Its formulary is fourteen weight-loss medications — compounded semaglutide, tirzepatide and liraglutide, brand Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza and Trulicity, the oral GLP-1s Foundayo and Rybelsus, and the non-GLP-1 orals Contrave, metformin, topiramate and zonisamide. That class is exactly what NAD+ therapy is not: large randomized controlled trials against hard weight and cardiometabolic endpoints. The qualifier that applies to every compounder applies here too — those trials tested the FDA-approved branded products, and a compounded copy inherits the molecule but not the trial data. Read against our own evidence pages, the summary is that GLP-1 drugs cause weight loss, NAD+ does not, and nothing on Found's menu addresses energy, cognition or longevity at all.

pricing

What it actually costs

advertised: "$49/mo" is the figure attached to the non-GLP-1 Generics Plan. It appears nowhere on `/plans-and-pricing`; the real table is an image inside the binding Offer Terms.
you pay: $89 a month with commercial insurance, or $149 cash-pay, for the Generics Plan bought a month at a time — billed every four weeks. $49 is the twelve-month insured rung and $99 the twelve-month cash rung. On the compounded GLP-1 plan the Offer Terms give $199 insured and $299 cash month to month, falling to $149 and $199 at twelve months.
the catch: Three stacked, and the third is the one nobody expects. First, $49 needs two conditions at once — a twelve-month commitment AND commercial insurance — and neither is attached to the figure where it is advertised. Second, billing is every four weeks, so a year is thirteen charges rather than twelve. Third, Found's "12 months" is 48 weeks, which is about eleven calendar months of coverage — so the commitment that unlocks the lowest rung buys less time than its name implies. Separately, the binding Offer Terms and the public pricing page disagree on three of the four compounded-GLP-1 cells; the Offer Terms are the document that binds.

Other money you will meet

Billing every four weeks means thirteen cycles a year, not twelve
Membership is refundable only within three days or before the first consult
Medications and lab kits are non-refundable once shipped, and renewals are non-refundable
Cancellation requires at least 48 hours' notice before renewal

source :: read at joinfound.com on 2026-08-08, in a browser that runs JavaScript.

fit

Who this is and is not for

Buy it if

Weight loss is your actual goal and you want the strongest named clinical bench in this category
You want a non-GLP-1 oral path — Contrave, metformin, topiramate or zonisamide — priced separately from the injectables
You have commercial insurance and will commit to a twelve-month plan, which is what the cheapest advertised figure actually requires
You want a company that discloses the limits of its own medical advisors rather than implying they see patients

Look elsewhere if

You want NAD+, a peptide, B-12 or anything for energy or cognition — Found's formulary is fourteen weight-loss drugs and nothing else
You want the advertised price: $49 needs both a year's commitment and insurance, and month to month is $89 or $149
You want the marketing page and the binding terms to say the same thing — on the compounded GLP-1 plan they disagree on three of four cells
You live in a state whose panel and whose selector disagree — New Mexico and California each contradict themselves on Found's own page

included

What is inside the price

consult: Yes — a clinician reviews the case and prescribes, inside a membership rather than as a per-visit charge. The membership is refundable only within three days or before the first consult, so the window to change your mind closes early.
labs: Lab kits are sold and are named in the refund policy as non-refundable once shipped. Nothing published makes them a gate on starting.
follow-ups: Included in the membership; the plan renews on its own cycle and cancellation needs 48 hours' notice.
human support: Found's own framing is behavioral: coaching and habit tooling sit alongside the medication rather than the medication being the whole offer.
supplies: Not itemized on the pages we read.
shipping: Not priced separately on the pages we read.

the_knock

What they would rather you skipped

Found's own binding Offer Terms contradict its own public pricing page on three of the four cells of the compounded GLP-1 plan. `/plans-and-pricing` advertises $99 and $169 at twelve months and $199 and $289 month to month; the Offer Terms — the document you actually agree to — say $149 and $199 at twelve months and $199 and $299 month to month. Only one of the four figures survives the crossing. And the real table is not text on a page: it is an image inside the terms, which means it cannot be read by a screen reader, cannot be searched, and cannot be found by anyone comparison-shopping the way a normal person does. Beside that sits the "$49", which is quoted as a monthly rate and requires both a twelve-month commitment and commercial insurance — while the twelve months in question is 48 weeks, roughly eleven calendar months, on a plan billed every four weeks so the year contains thirteen charges. Each of those three details individually is a rounding error; together they are the difference between the number advertised and the number paid. The state page contradicts itself twice on the same screen. We are paid a commission when a reader starts care through our link to Found, and we still say the clinical bench here is the best in this module — both of those are in this review because leaving either one out would misrepresent the company.

And the rest

The binding Offer Terms disagree with the public pricing page on three of four compounded-GLP-1 cells
The real price table is an image inside the terms — unreadable by a screen reader and unfindable by search
The advertised "$49" requires both a twelve-month commitment and commercial insurance; month to month it is $89 insured or $149 cash
Billing is every four weeks (thirteen cycles a year) and "12 months" is 48 weeks, about eleven calendar months of coverage
The state page contradicts itself twice — New Mexico is absent from the selector but renders a plans panel, and California is in the accepted list while its own panel says no plans are available
No dispensing pharmacy is named, only the 503A category
It sells no NAD+, no peptide and nothing for energy or cognition, and nothing on this site ranks it as an NAD+ provider
This site earns a commission when a reader starts care through this link

tools

Work out your own number

NAD+ therapy cost calculator

visit Found

Every figure on this page was read on Found’s own site on 2026-08-08 in a browser that runs JavaScript, and prices change without notice. Read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.